$28.5 Million is the total value of CVI Holdings, LLC's 37 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 97.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TIMKENSTEEL CORPnote 6.000% 6/0 | $8,429,000 | -21.4% | 10,455,000 | 0.0% | 29.60% | +95.9% | ||
| ZGYHU | New | YUNHONG INTLunit 99/99/9999 | $3,325,000 | – | 350,000 | +100.0% | 11.68% | – |
| New | INOVIO PHARMACEUTICALS INCnote 6.500% 3/0 | $2,984,000 | – | 2,000,000 | +100.0% | 10.48% | – | |
| ENLV | New | ENLIVEX THERAPEUTICS LTD | $1,805,000 | – | 385,621 | +100.0% | 6.34% | – |
| SENSEONICS HLDGS INCnote 5.250% 2/0 | $1,479,000 | -0.9% | 1,500,000 | 0.0% | 5.19% | +146.9% | ||
| ADMP | New | ADAMIS PHARMACEUTICALS CORP | $1,214,000 | – | 3,397,916 | +100.0% | 4.26% | – |
| BXRX | New | BAUDAX BIO INC | $1,072,000 | – | 432,325 | +100.0% | 3.76% | – |
| CLSN | New | CELSION CORPORATION | $1,030,000 | – | 1,139,110 | +100.0% | 3.62% | – |
| ESGC | New | EROS INTL PLC | $794,000 | – | 480,962 | +100.0% | 2.79% | – |
| PHIO | New | PHIO PHARMACEUTICALS CORP | $637,000 | – | 360,094 | +100.0% | 2.24% | – |
| VSTM | New | VERASTEM INC | $614,000 | – | 232,559 | +100.0% | 2.16% | – |
| KTOV | New | KITOV PHARMA LTDsponsored ads | $605,000 | – | 1,977,554 | +100.0% | 2.12% | – |
| RESN | New | RESONANT INC | $600,000 | – | 405,274 | +100.0% | 2.11% | – |
| REPL | Sell | REPLIMUNE GROUP INC | $584,000 | -90.1% | 58,595 | -85.7% | 2.05% | -75.3% |
| PTE | New | POLARITYTE INC | $487,000 | – | 451,240 | +100.0% | 1.71% | – |
| NOVN | New | NOVAN INC | $435,000 | – | 2,914,854 | +100.0% | 1.53% | – |
| SVRA | SAVARA INC | $434,000 | -52.7% | 204,666 | 0.0% | 1.52% | +18.0% | |
| AMRS | Sell | AMYRIS INC | $288,000 | -95.5% | 112,639 | -94.6% | 1.01% | -88.8% |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $266,000 | – | 208,074 | +100.0% | 0.93% | – |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $246,000 | -69.3% | 181,888 | -72.8% | 0.86% | -23.4% |
| FAMI | Buy | FARMMI INC | $229,000 | +95.7% | 426,387 | +173.2% | 0.80% | +387.3% |
| BLPH | New | BELLEROPHON THERAPEUTICS INC | $210,000 | – | 19,200 | +100.0% | 0.74% | – |
| CVM | New | CEL SCI CORPput | $198,000 | – | 17,200 | +100.0% | 0.70% | – |
| MCF | Sell | CONTANGO OIL & GAS CO | $137,000 | -94.7% | 91,120 | -87.0% | 0.48% | -86.7% |
| RGLS | Sell | REGULUS THERAPEUTICS INC | $129,000 | -62.5% | 280,152 | -27.4% | 0.45% | -6.6% |
| SLGL | New | SOL GEL TECHNOLOGIES | $71,000 | – | 10,068 | +100.0% | 0.25% | – |
| VERBW | VERB TECHNOLOGY CO INC*w exp 03/14/202 | $67,000 | -38.0% | 240,000 | 0.0% | 0.24% | +54.6% | |
| XCUR | Sell | EXICURE INC | $66,000 | -98.1% | 44,798 | -96.3% | 0.23% | -95.3% |
| CHEKZ | CHECK CAP LTD*w exp 05/03/202 | $23,000 | +43.8% | 136,364 | 0.0% | 0.08% | +252.2% | |
| SGLBW | SIGMA LABS INC*w exp 02/15/202 | $9,000 | -60.9% | 48,100 | 0.0% | 0.03% | 0.0% | |
| ARTLW | ARTELO BIOSCIENCES INC*w exp 06/25/202 | $4,000 | -78.9% | 65,000 | 0.0% | 0.01% | -48.1% | |
| BNTCW | BENITEC BIOPHARMA LTD*w exp 08/14/202 | $2,000 | -50.0% | 50,000 | 0.0% | 0.01% | +16.7% | |
| PSTVZ | PLUS THERAPEUTICS INC*w exp 05/28/202 | $2,000 | +100.0% | 259,200 | 0.0% | 0.01% | +600.0% | |
| AMRHW | Sell | AMERI HLDGS INC*w exp 11/08/202 | $1,000 | -75.0% | 85,231 | -13.6% | 0.00% | -33.3% |
| MDGSW | MEDIGUS LTD*w exp 07/23/202 | $1,000 | -83.3% | 63,286 | 0.0% | 0.00% | -50.0% | |
| CREXW | CREATIVE REALITIES INC*w exp 11/09/202 | $1,000 | 0.0% | 15,000 | 0.0% | 0.00% | +300.0% | |
| UUUUWS | ENERGY FUELS INC*w exp 09/20/202 | $0 | – | 277,777 | 0.0% | 0.00% | – | |
| FPAYW | Exit | FLEXSHOPPER INC*w exp 09/28/202 | $0 | – | -38,443 | -100.0% | -0.08% | – |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -272,454 | -100.0% | -0.15% | – |
| CCCL | Exit | CHINA CERAMICS CO LTD | $0 | – | -199,817 | -100.0% | -0.19% | – |
| BVXVW | Exit | BIONDVAX PHARMACEUTICALS LTD*w exp 05/15/202 | $0 | – | -72,800 | -100.0% | -0.27% | – |
| AUMN | Exit | GOLDEN MINERALS CO | $0 | – | -1,021,257 | -100.0% | -0.45% | – |
| AMPE | Exit | AMPIO PHARMACEUTICALS INC | $0 | – | -556,492 | -100.0% | -0.46% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -148,952 | -100.0% | -0.72% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -643,682 | -100.0% | -0.83% | – |
| ACHV | Exit | ACHIEVE LIFE SCIENCE INC | $0 | – | -1,169,940 | -100.0% | -0.87% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -83,001 | -100.0% | -1.81% | – |
| NAK | Exit | NORTHERN DYNASTY MINERALS LT | $0 | – | -3,280,759 | -100.0% | -1.98% | – |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -452,246 | -100.0% | -3.31% | – |
| HEXO | Exit | HEXO CORP | $0 | – | -2,328,835 | -100.0% | -5.22% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -3,466,899 | -100.0% | -6.45% | – | |
| MNKD | Exit | MANNKIND CORP | $0 | – | -3,705,310 | -100.0% | -6.73% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -5,227,371 | -100.0% | -24.08% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SENSEONICS HLDGS INC | 20 | Q4 2022 | 5.2% |
| CHECK CAP LTD | 20 | Q1 2023 | 0.2% |
| MEDIGUS LTD | 19 | Q2 2023 | 0.1% |
| VERB TECHNOLOGY CO INC | 18 | Q3 2023 | 0.2% |
| VERIFYME INC | 14 | Q3 2023 | 0.0% |
| GEOVAX LABS INC | 13 | Q3 2023 | 0.0% |
| ENERGY FUELS INC | 13 | Q2 2021 | 0.0% |
| BREEZE HOLDINGS ACQUISITN CO | 12 | Q3 2023 | 0.1% |
| CREATIVE REALITIES INC | 12 | Q3 2021 | 0.0% |
| TIMKENSTEEL CORP | 11 | Q3 2020 | 29.6% |
View CVI Holdings, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View CVI Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.